Cargando…
Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
BACKGROUND: Acute cellular rejection (ACR) is a major risk factor for chronic lung allograft dysfunction after lung transplantation. Acute cellular rejection can persist or recur despite augmentation of immunosuppression by conventional methods. There are limited therapeutic options in treating thes...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959344/ https://www.ncbi.nlm.nih.gov/pubmed/29796421 http://dx.doi.org/10.1097/TXD.0000000000000790 |